RxIndia
Loading clinical data...
Loading clinical data...
1. Highintensity statin in ASCVD — In all patients with established atherosclerotic cardiovascular disease (postMI, stroke, PAD), start atorvastatin 4...
Ezetimibe is the preferred addon agent when statin alone does not achieve LDLC targets — provides additional 20–25% LDLC reduction Firstline monothe...
1. Potency advantage: Rosuvastatin is the most potent statin per milligram — 10 mg rosuvastatin provides LDLC reduction equivalent to approximately 20...